High Affinity Nerve Growth Factor Receptor Market
High Affinity Nerve Growth Factor Receptor Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
High Affinity Nerve Growth Factor Receptor Market Size and Growth
The High Affinity Nerve Growth Factor Receptor market is experiencing robust growth, driven by increasing neurological disorders and advancing research. Market size is projected to reach approximately $500 million by 2028, reflecting a compound annual growth rate of around 8%. Innovative therapies and rising investments in biopharmaceuticals fuel this expansion. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Array BioPharma Inc
◍ Astellas Pharma Inc
◍ AstraZeneca Plc
◍ Daiichi Sankyo Co Ltd
◍ Dompe Farmaceutici SpA
◍ Genzyme Corp
◍ Handok Inc
◍ Ignyta Inc
◍ Loxo Oncology Inc
◍ Merck & Co Inc
◍ Nerviano Medical Sciences Srl
◍ Plexxikon Inc
◍ Proximagen Ltd
◍ Rottapharm Biotech Srl
◍ Sienna Biopharmaceuticals Inc
◍ Tiziana Life Sciences Plc
The High Affinity Nerve Growth Factor Receptor Market features companies like Array BioPharma, Astellas Pharma, and Merck, focusing on drug development for neurodegenerative diseases. Their innovative therapies drive market growth through research and partnerships. Sales revenues include:
- Merck: $58 billion
- Astellas Pharma: $12 billion - AstraZeneca: $37 billion.
Request Sample Report
Market Segmentation
By Application By Product
Bile Duct Cancer ◍ Papillary Thyroid Cancer ◍ Low Back Pain
Lung Cancer
Others
◍ ASP-7962 ◍ AZD-7451
BNN-27
Cenegermin
CRB-0089
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
